Wondering if Recursion Pharmaceuticals at around $4.83 is a beaten down bargain or a value trap? This breakdown walks through what the current market price is really implying. The stock has bounced ...

Merve Ceylan is a dietitian and health writer with four years of experience writing for companies in the nutrition and health industry. Red, orange, and yellow bell peppers have more vitamin C than ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

A now patched flaw in Microsoft 365 Copilot let attackers turn its diagram tool, Mermaid, into a data exfiltration channel–fetching and encoding emails through hidden instructions in Office documents.

Recursion Pharmaceuticals developed a promising artificial intelligence (AI) platform for drug discovery and development. The company's clinical-stage pipeline is just the tip of the iceberg of its ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

A National Guard military vehicle crashed into a car in Washington, D.C., on Wednesday morning, injuring the driver. The incident comes after President Trump ordered hundreds of Guard troops to the ...

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $5.52, marking a +2.41% move from the previous day. The stock outperformed the S&P 500, which registered a daily gain of 0.54% ...

The last character of the text is cut off when rendering Mermaid diagrams using the “Recursive Sans” font. This issue only occurs when the block has only one line. It does not happen with blocks ...

Have you ever watched a senior leader speak and thought, “How do they always know what to say and do?” They make big decisions look effortless and handle unexpected situations like it’s no big deal.